TABLE 1 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 57
TABLE 2 EUROPE ASSAY KITS & REAGENTS MARKET, BY REGION,

2016 - 2025 (USD MILLION) 58
TABLE 3 EUROPE SYSTEMS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 59

TABLE 4 EUROPE SOFTWARES MARKET, BY REGION, 2016 - 2025 (USD MILLION) 60

TABLE 5 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY TEST,

2016 - 2025 (USD MILLION) 63
TABLE 6 EUROPE INDIRECT IMMUNOFLUORESCENCE MARKET, BY REGION,

2016 - 2025 (USD MILLION) 64
TABLE 7 EUROPE ELISA MARKET, BY REGION, 2016 - 2025 (USD MILLION) 65

TABLE 8 EUROPE MULTIPLEX TESTING MARKET, BY REGION,

2016 - 2025 (USD MILLION) 66
TABLE 9 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 69
TABLE 10 EUROPE RHEUMATOID ARTHRITIS MARKET, BY REGION,

2016 - 2025 (USD MILLION) 70
TABLE 11 EUROPE SYSTEMIC LUPUS ERYTHEMATOSUS MARKET, BY REGION,

2016 - 2025 (USD MILLION) 71
TABLE 12 EUROPE SJOGREN'S SYNDROME MARKET, BY REGION,

2016 - 2025 (USD MILLION) 72
TABLE 13 EUROPE SCLERODERMA MARKET, BY REGION,

2016 - 2025 (USD MILLION) 73
TABLE 14 EUROPE POLYMYOSITIS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 74

TABLE 15 EUROPE OTHERS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 75

TABLE 16 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 78
TABLE 17 EUROPE HOSPITALS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 79

TABLE 18 EUROPE CLINICS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 80

TABLE 19 EUROPE PHYSICIAN OFFICE LABORATORIES MARKET, BY REGION,

2016 - 2025 (USD MILLION) 81
TABLE 20 EUROPE OTHERS MARKET, BY REGION, 2016 - 2025 (USD MILLION) 82

TABLE 21 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY REGION,

2016 - 2025 (USD MILLION) 90
TABLE 22 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY COUNTRY,

2016-2025 (USD MILLION) 116

TABLE 23 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 117
TABLE 24 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 117
TABLE 25 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 118
TABLE 26 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 119
TABLE 27 GERMANY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 120
TABLE 28 GERMANY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 120
TABLE 29 GERMANY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 121
TABLE 30 GERMANY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 122
TABLE 31 FRANCE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 123
TABLE 32 FRANCE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 123
TABLE 33 FRANCE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 124
TABLE 34 FRANCE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 125
TABLE 35 U.K. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 126
TABLE 36 U.K. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 126
TABLE 37 U.K. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 127
TABLE 38 U.K. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 128
TABLE 39 ITALY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 129
TABLE 40 ITALY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 129
TABLE 41 ITALY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 130
TABLE 42 ITALY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 131
TABLE 43 SPAIN ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 132
TABLE 44 SPAIN ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 132
TABLE 45 SPAIN ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 133
TABLE 46 SPAIN ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 134
TABLE 47 SWITZERLAND ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016 - 2025 (USD MILLION) 135
TABLE 48 SWITZERLAND ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016 - 2025 (USD MILLION) 135
TABLE 49 SWITZERLAND ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016 - 2025 (USD MILLION) 136
TABLE 50 SWITZERLAND ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016 - 2025 (USD MILLION) 137
TABLE 51 NETHERLANDS ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016 - 2025 (USD MILLION) 138

TABLE 52 NETHERLANDS ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY TEST, 2016 - 2025 (USD MILLION) 138

TABLE 53 NETHERLANDS ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY DISEASE, 2016 - 2025 (USD MILLION) 139

TABLE 54 NETHERLANDS ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY END USER, 2016 - 2025 (USD MILLION) 140

TABLE 55 BELGIUM ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016 - 2025 (USD MILLION) 141

TABLE 56 BELGIUM ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY TEST, 2016 - 2025 (USD MILLION) 141

TABLE 57 BELGIUM ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY DISEASE, 2016 - 2025 (USD MILLION) 142

TABLE 58 BELGIUM ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY END USER, 2016 - 2025 (USD MILLION) 143

TABLE 59 RUSSIA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016 - 2025 (USD MILLION) 144

TABLE 60 RUSSIA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY TEST, 2016 - 2025 (USD MILLION) 144

TABLE 61 RUSSIA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY DISEASE, 2016 - 2025 (USD MILLION) 145

TABLE 62 RUSSIA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY END USER, 2016 - 2025 (USD MILLION) 146

TABLE 63 TURKEY ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016 - 2025 (USD MILLION) 147

TABLE 64 TURKEY ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY TEST, 2016 - 2025 (USD MILLION) 147

TABLE 65 TURKEY ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY DISEASE, 2016 - 2025 (USD MILLION) 148

TABLE 66 TURKEY ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY END USER, 2016 - 2025 (USD MILLION) 149

TABLE 67 REST OF EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016 - 2025 (USD MILLION) 150

LIST OF FIGURE

Figures List
Figure 1 Europe Anti-Nuclear Antibody Test Market; Segmentation 27
Figure 2 Europe Anti-Nuclear Antibody Test Market; Data Triangulation 30
Figure 3 Europe Anti-Nuclear Antibody Test Market ; Research Snapshot 31
Figure 4 Europe Anti-Nuclear Antibody Test Market ; Bottom Up Approach 32
Figure 5 Europe Anti-Nuclear Antibody Test Market; Top Down Approach 32
Figure 6 Europe Anti-Nuclear Antibody Test Market ;
Interview Demographics 33
Figure 7 Europe Anti-Nuclear Antibody Test Market ; Segmentation 46
Figure 8 Europe Anti-Nuclear Antibody Test Market; By Product Type, 2017 56
Figure 9 Europe Anti-Nuclear Antibody Test Market; By Test, 2017 62
Figure 10 Europe Anti-Nuclear Antibody Test Market; By Disease, 2017 68
Figure 11 Europe Anti-Nuclear Antibody Test Market; By End User, 2017 77
Figure 12 Europe Anti-Nuclear Antibody Test Market Snapshot (2017) 85
Figure 13 Europe Anti-Nuclear Antibody Test Market; By Geography (2017) 86
Figure 14 Europe Anti-Nuclear Antibody Test Market; By Geography (2018) 87
Figure 15 Europe Anti-Nuclear Antibody Test Market; By Country (2017 & 2025) 88
Figure 16 Europe Anti-Nuclear Antibody Test Market;
By Product Type (2018 & 2025) 89
Figure 17 Europe Anti-Nuclear Antibody Test Market; Snapshot (2017) 111
Figure 18 Europe Anti-Nuclear Antibody Test Market; By Country (2017) 112
Figure 19 Europe Anti-Nuclear Antibody Test Market ;
By Country (2018 & 2025) 113
Figure 20 Europe Anti-Nuclear Antibody Test Market, By Country (2017 & 2025) 114
Figure 21 Europe Anti-Nuclear Antibody Test Market, By Product (2018 & 2025) 115
Figure 22 Europe Anti-Nuclear Antibody Test Market; Company Share 2017 (%) 222